Gould MN - Search Results

1

Phase I clinical trial of perillyl alcohol administered daily.

Ripple GH, Gould MN, Stewart JA, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Pomplun M, Wilding G, Bailey HH. Ripple GH, et al. Among authors: gould mn. Clin Cancer Res. 1998 May;4(5):1159-64. Clin Cancer Res. 1998. PMID: 9607573 Clinical Trial.

2

Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.

Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Binger K, Tutsch KD, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey HH. Ripple GH, et al. Among authors: gould mn. Clin Cancer Res. 2000 Feb;6(2):390-6. Clin Cancer Res. 2000. PMID: 10690515 Clinical Trial.

3

Human metabolism of the experimental cancer therapeutic agent d-limonene.

Crowell PL, Elson CE, Bailey HH, Elegbede A, Haag JD, Gould MN. Crowell PL, et al. Among authors: gould mn. Cancer Chemother Pharmacol. 1994;35(1):31-7. doi: 10.1007/BF00686281. Cancer Chemother Pharmacol. 1994. PMID: 7987974

4

Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.

Ariazi EA, Satomi Y, Ellis MJ, Haag JD, Shi W, Sattler CA, Gould MN. Ariazi EA, et al. Among authors: gould mn. Cancer Res. 1999 Apr 15;59(8):1917-28. Cancer Res. 1999. PMID: 10213501

5

Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway.

Berchtold CM, Chen KS, Miyamoto S, Gould MN. Berchtold CM, et al. Among authors: gould mn. Cancer Res. 2005 Sep 15;65(18):8558-66. doi: 10.1158/0008-5472.CAN-04-4072. Cancer Res. 2005. PMID: 16166337

6

Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene.

Haag JD, Gould MN. Haag JD, et al. Among authors: gould mn. Cancer Chemother Pharmacol. 1994;34(6):477-83. doi: 10.1007/BF00685658. Cancer Chemother Pharmacol. 1994. PMID: 7923558

7

Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol.

Ren Z, Gould MN. Ren Z, et al. Among authors: gould mn. Cancer Lett. 1994 Jan 30;76(2-3):185-90. doi: 10.1016/0304-3835(94)90396-4. Cancer Lett. 1994. PMID: 8149348

8

Induction of differentiation in neuro-2A cells by the monoterpene perillyl alcohol.

Shi W, Gould MN. Shi W, et al. Among authors: gould mn. Cancer Lett. 1995 Aug 16;95(1-2):1-6. doi: 10.1016/0304-3835(95)03859-u. Cancer Lett. 1995. PMID: 7656215

9

Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol.

Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL. Mills JJ, et al. Among authors: gould mn. Cancer Res. 1995 Mar 1;55(5):979-83. Cancer Res. 1995. PMID: 7867007

10

Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells.

Ren Z, Elson CE, Gould MN. Ren Z, et al. Among authors: gould mn. Biochem Pharmacol. 1997 Jul 1;54(1):113-20. doi: 10.1016/s0006-2952(97)00151-2. Biochem Pharmacol. 1997. PMID: 9296357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters